AHFS Clinical Drug Information
AHFS Drug Information
AHFS DI Essentials
AHFS Patient Medication Information
AHFS Medication Guides
AHFS Pharmacologic-Therapeutic Classification
For Subscribers
This section is intended for print subscribers of AHFS Drug Information and includes electronic only monographs. To access, you will be required to login with a username and password, which can be found in the preface of each annual edition of AHFS DI.
Resources
ASHP Drug Shortages Center
Drug Class Assignments and Reassignments
Investigational Drug Services Resource Center
Medications and Suicidality Resource Center
REMS Resource Center
Sterile Compounding Resource Center
Off-label Uses in AHFS
National Alert Network
ASHP Best Practices
ASHP Connect
AHFS Blog
Emergency Use Authorization (EUA) for bamlanivimab
12 November, 2020Emergency Use Authorization (EUA) for Convalescent Plasma
23 August, 2020FDA Revokes EUA for Chloroquine and Hydroxychloroquine
15 June, 2020
About ASHP
ASHP represents pharmacists who serve as patient care providers in acute and ambulatory settings. The organization’s nearly 55,000 members include pharmacists, student pharmacists, and pharmacy technicians. For more than 75 years, ASHP has been at the forefront of efforts to improve medication use and enhance patient safety. For more information about the wide array of ASHP activities and the many ways in which pharmacists advance healthcare, visit ASHP’s website, www.ashp.org, or its consumer website, www.safemedication.com.
ASHP
4500 East-West Highway, Suite 900
Bethesda, Maryland 20814
Phone: 1-866-279-0681
Email: custserv@ashp.org
